{"id":"W4389029721","doi":"10.1093/ofid/ofad500.1532","title":"1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients","year":2023,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Janssen Biotech; Genentech; National Institutes of Health; Basilea Pharmaceutica; Astellas Pharma; Sanofi; Nabriva Therapeutics; Moderna; Sanofi Pasteur; Amplyx; KU Leuven; Jazz Pharmaceuticals; Gilead Sciences; Pfizer; Melinta Therapeutics; Astellas Pharma Global Development; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Aspergillosis; Adverse effect; Mucormycosis; Incidence (geometry); Case fatality rate; Population; Neutropenia; Internal medicine; Surgery; Pediatrics; Toxicity; Epidemiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107333,0.0002265331,0.0005535682,0.0002142962,0.0001326162,0.0004745651,0.0001500503,0.0003231083,0.001469218],"category_scores_gemma":[0.001196392,0.00008939723,0.000575237,0.000237754,0.0001619862,0.0002265905,0.0001757639,0.0004411139,0.0002756179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000439582,"about_ca_system_score_gemma":0.0007595732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004800803,"about_ca_topic_score_gemma":0.0006757646,"domain_scores_codex":[0.9994991,0.0002255015,0.00006180922,0.00006161646,0.0000980725,0.00005393527],"domain_scores_gemma":[0.9988745,0.0002077057,0.0005823307,0.00003601112,0.0001188707,0.0001806695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1938916,0.007215533,0.4679696,0.001851681,0.001679581,0.001227611,0.0002834569,0.002843329,0.0195137,0.0003793752,0.0049385,0.2982061],"study_design_scores_gemma":[0.03218797,0.3027976,0.63085,0.000526846,0.001117523,0.002742534,0.000315066,0.003379041,0.01016865,0.0002178693,0.01564605,0.00005084349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930705,0.004044994,0.0001746627,0.00007541304,0.0000317319,0.0001949484,0.0009537831,0.00001351782,0.001440319],"genre_scores_gemma":[0.9968766,0.001023048,0.0003373831,0.0001496934,0.00004755602,0.0001685345,0.001052895,0.000003580514,0.000340717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001469218,"threshold_uncertainty_score":0.005856216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02166402858186709,"score_gpt":0.3032928494492307,"score_spread":0.2816288208673636,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}